DermBiont (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- October 24, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $35,200,000
Company Info
- Founders
- Karl Beutner, M.D., Ph.D.
- Company Description
- DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
- Market
- Dermatology
- Location
- Boston, MA, USA
- Coinvestors
- Civilization Ventures, Double Point Ventures, Olive Tree Capital, Viking Global Investors